News from soligenix, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:SNGX)

Feb 02, 2016, 07:00 ET

Soligenix to Present at Source Capital Group's 2016 Disruptive Growth & Healthcare Conference

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

Jan 26, 2016, 07:00 ET

Soligenix Provides 2016 Business Outlook

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Dec 16, 2015, 07:00 ET

Soligenix Announces Positive Preliminary Results from its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Dec 16, 2015, 07:00 ET

Soligenix Will Host a Conference Call to Update Shareholders on Recent Positive Clinical Results and Company Development Milestones

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Dec 14, 2015, 07:00 ET

Soligenix Announces Initiation of its Pivotal Phase 3 Clinical Trial of SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Dec 09, 2015, 07:00 ET

Soligenix Receives $490,000 in Non-Dilutive Financing from New Jersey's Technology Business Tax Certificate Transfer Program

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Dec 04, 2015, 07:30 ET

Soligenix Provides Clinical Program Updates for December 2015

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products...

Nov 12, 2015, 07:00 ET

Soligenix Announces Recent Highlights and Third Quarter 2015 Financial Results

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Oct 05, 2015, 07:15 ET

Soligenix to Present at the 3rd Annual BioNJ CEO Summit

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Aug 31, 2015, 07:00 ET

Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical...

Aug 27, 2015, 07:15 ET

Soligenix Receives Additional NIAID Funding to Advance Development of OrbeShield™ in GI ARS

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical...

Aug 19, 2015, 07:00 ET

Soligenix Receives Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet...

Aug 12, 2015, 07:00 ET

Soligenix Announces Recent Highlights and Second Quarter 2015 Financial Results

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet...

Aug 04, 2015, 07:30 ET

Soligenix Receives Orphan Drug Designation from the European Commission for SGX301 as a Treatment for Cutaneous T-Cell Lymphoma

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet...

Aug 03, 2015, 07:30 ET

Soligenix Enters into a $10 Million Equity Purchase Agreement

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical...

Jun 23, 2015, 07:15 ET

Soligenix Announces Collaboration with the National Organization for Rare Disorders and the Cutaneous Lymphoma Foundation in Advancing its Phase 3 Study of SGX301 for the Treatment of Cutaneous T-Cell Lymphoma

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet...

Jun 02, 2015, 07:00 ET

Soligenix Announces Publication of Successful Application of its Heat Stabilization Technology to a Human Papillomavirus Vaccine

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical...

May 28, 2015, 07:00 ET

Soligenix Announces Collaboration with the University of Hawai'i at Manoa and Hawaii Biotech to Develop Heat Stable Ebola Vaccine

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet...

May 14, 2015, 07:00 ET

Soligenix Announces First Quarter 2015 Highlights and Financial Results

Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical...

May 13, 2015, 07:00 ET

Soligenix Announces Development Agreement with Emergent BioSolutions

 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet...